Citation Impact
Citing Papers
The p53 Tumor Suppressor Network Is a Key Responder to Microenvironmental Components of Chronic Inflammatory Stress
2005
Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis
2008 Standout
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Nasopharyngeal carcinoma
2005 Standout
Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time
2002
Le traitement chirurgical du cancer bronchique non à petites cellules
2004
Tolerance of rat spinal cord to continuous interstitial irradiation
1998
The role of external beam radiotherapy in the management of differentiated thyroid cancer
2000
Inoperable Symptomatic Recurrent Thyroid Cancers: Preliminary Result of Radiofrequency Ablation
2011
PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma
2001
The management of advanced thyroid cancer
2004
Oxidative stress, aging, and diseases
2018 Standout
The third dimension bridges the gap between cell culture and live tissue
2007 Standout
Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivationviaarginine deiminase
2006
Genes that mediate breast cancer metastasis to the brain
2009 StandoutNature
Thyroid cancer
2016 Standout
Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer
2001 Standout
Patterns of relapse following radiotherapy for differentiated thyroid cancer: Implication for target volume delineation
2008
Papillary microcarcinoma of the thyroid—Prognostic significance of lymph node metastasis and multifocality
2003 Standout
Guidelines on the radical management of patients with lung cancer
2010
Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer
2010
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
External Beam Radiotherapy in the Management of Differentiated Thyroid Cancer
2003
Neurocognitive Function of Patients with Brain Metastasis Who Received Either Whole Brain Radiotherapy Plus Stereotactic Radiosurgery or Radiosurgery Alone
2007
Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage IIIA/B nonsmall cell lung carcinoma
2001
Down-regulation of p21 contributes to apoptosis induced by HPV E6 in human mammary epithelial cells
2005
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Head and neck cancer
2008 Standout
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
External beam radiotherapy for differentiated thyroid cancer
2005
Changes in Clinical Presentation, Management and Outcome in 1348 Patients with Differentiated Thyroid Carcinoma: Experience in a Single Institute in Hong Kong, 1960–2000
2003
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial
2016
Preoperative chemotherapy for non-small cell lung cancer
2001
Risk of Malignancy in Nonpalpable Thyroid Nodules: Predictive Value of Ultrasound and Color-Doppler Features
2002 Standout
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
External-beam radiation therapy in the treatment of differentiated thyroid cancer
1999
Value of external irradiation for locally advanced papillary thyroid cancer
2003
Surgery for Papillary Thyroid Carcinoma
2010
Risk factors for brain relapse in patients with metastatic breast cancer
2004
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
HPV-associated head and neck cancer: a virus-related cancer epidemic
2010 Standout
Role of External Beam Radiotherapy in Patients With Advanced or Recurrent Nonanaplastic Thyroid Cancer: Memorial Sloan-Kettering Cancer Center Experience
2008
p21 in cancer: intricate networks and multiple activities
2009 Standout
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Effect of Irradiation Fluence Rate on the Efficacy of Photodynamic Therapy and Tumor Oxygenation in Meta-Tetra (Hydroxyphenyl) Chlorin (mTHPC)-Sensitized HT29 Xenografts in Nude Mice1
2002
Current status of angiogenesis inhibitors combined with radiation therapy
2006
Photodynamic therapy and anti-tumour immunity
2006 Standout
Is there a role for radiation therapy in the management of hürthle cell carcinoma?
2003
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
2015 Standout
The magic of the hypoxia-signaling cascade
2008
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
2006 Standout
Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer
2007 Standout
Impact of extent of resection for thyroid cancer invading the aerodigestive tract on surgical morbidity, local recurrence, and cancer-specific survival
2010
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
Radiation pneumonitis and pulmonary fibrosis in non–small-cell lung cancer: Pulmonary function, prediction, and prevention
2005
The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy
1996
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Markers of oxidant stress that are clinically relevant in aging and age-related disease
2013
Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy
1996
Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy
2002
A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature
2001
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
2001 Standout
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years
2005
Effect of VEGF receptor-2 antibody on vascular function and oxygenation in spontaneous and transplanted tumors
2004
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Postoperative External Beam Radiotherapy for Differentiated Thyroid Cancer: Outcomes and Morbidity With Conformal Treatment
2008
Association Between Pharmaceutical Support and Basic Science Research on Erythropoiesis-Stimulating Agents
2010
A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma
2002
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial
2009 Standout
Outcome after Treatment of High-Risk Papillary and Non-Hurthle-Cell Follicular Thyroid Carcinoma
1998
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
2012 StandoutNobel
In vitro evaluation of Taxol® combined with radiations in human squamous cell carcinoma spheroids
1996
Drug Resistance and the Solid Tumor Microenvironment
2007 Standout
Targeting Arginine-Dependent Cancers with Arginine-Degrading Enzymes: Opportunities and Challenges
2013
HIF-1beta determines ABCA1 expression under hypoxia in human macrophages
2009 StandoutNobel
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
2012
Differentiated Thyroid Cancer with Extrathyroidal Extension: Prognosis and the Role of External Beam Radiotherapy
2010
The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma
1998
Three A's of repopulation during fractionated irradiation of squamous epithelia: Asymmetry loss, Acceleration of stem-cell divisions and Abortive divisions
1997
Early changes in mouse urinary bladder function following fractionated X irradiation.
1992
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Die Rolle der externen Strahlentherapie bei der Behandlung des Schilddrüsenkarzinoms
2010
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases
2016 Standout
Pathophysiologic Effects of Vascular-Targeting Agents and the Implications for Combination with Conventional Therapies
2006
Factors Affecting the Risk of Brain Metastases After Definitive Chemoradiation for Locally Advanced Non–Small-Cell Lung Carcinoma
2001
Management of recurrent and persistent metastatic lymph nodes in well‐differentiated thyroid cancer: A multifactorial decision‐making guide for the thyroid cancer care collaborative
2014
Survival and Neurologic Outcomes in a Randomized Trial of Motexafin Gadolinium and Whole-Brain Radiation Therapy in Brain Metastases
2003
The role of erythropoietin and its receptor in growth, survival and therapeutic response of human tumor cells
2010
Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996
2000
Neurocognitive Function and Progression in Patients With Brain Metastases Treated With Whole-Brain Radiation and Motexafin Gadolinium: Results of a Randomized Phase III Trial
2003
Hyperfractionated Accelerated Chemoradiation With Concurrent Fluorouracil-Mitomycin Is More Effective Than Dose-Escalated Hyperfractionated Accelerated Radiation Therapy Alone in Locally Advanced Head and Neck Cancer: Final Results of the Radiotherapy Cooperative Clinical Trials Group of the German Cancer Society 95-06 Prospective Randomized Trial
2005
Three-dimensional cell cultures: from molecular mechanisms to clinical applications
1997
Phase III Trial of Prophylactic Cranial Irradiation Compared With Observation in Patients With Locally Advanced Non–Small-Cell Lung Cancer: Neurocognitive and Quality-of-Life Analysis
2010
Differentiated Thyroid Cancer: Management of Patients with Radioiodine Nonresponsive Disease
2012
Value of 18F-Fluoro-2-Deoxy-d -Glucose-Positron Emission Tomography/Computed Tomography in Non–Small-Cell Lung Cancer for Prediction of Pathologic Response and Times to Relapse after Neoadjuvant Chemoradiotherapy
2006
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2008 Standout
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer
2004 Standout
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
An evidence‐based review of poorly differentiated thyroid cancer
2007
External beam radiotherapy with or without concurrent chemotherapy in advanced or recurrent non-anaplastic non-medullary thyroid cancer
2014
Guidelines for the management of thyroid cancer
2014 Standout
Neurobehavioral Status and Health-Related Quality of Life in Newly Diagnosed High-Grade Glioma Patients
2001
Metastatic Behavior of Breast Cancer Subtypes
2010 Standout
Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial
2014 Standout
Industry sponsorship and research outcome
2017 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Thyroid carcinoma
2003 Standout
Management of invasive well‐differentiated thyroid cancer: An American head and neck society consensus statement: AHNS consensus statement
2014
Characterization and validation of noninvasive oxygen tension measurements in human glioma xenografts by 19F-MR relaxometry
1999
Long-Term Survival Associated With Complete Resection After Induction Chemotherapy in Stage IIIA (N2) and IIIB (T4N0-1) Non–Small-Cell Lung Cancer Patients: The Spanish Lung Cancer Group Trial 9901
2007
Works of Georg Stüben being referenced
Radiation sensitivity of lymphocytes from healthy individuals and cancer patients as measured by the comet assay
2001
Impact of Anemia Prevention by Recombinant Human Erythropoietin on the Sensitivity of Xenografted Glioblastomas to Fractionated Irradiation
2003
The effect of combined nicotinamide and carbogen treatments in human tumour xenografts: oxygenation and tumour control studies
1998
Differentiated thyroid cancer: Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4)
1996
Quiescent S-phase cells as indicators of extreme physiological conditions in human tumor xenografts
1999
Heterogeneity in the fractionation sensitivities of human tumor cell lines: Studies in a three-dimensional model system
1995
Preoperative chemoradiotherapy and surgery for selected non-small cell lung cancer IIIB subgroups: long-term results
1999
Estimation of repair parameters in mouse lip mucosa during continuous and fractionated low dose-rate irradiation
1991
Induction Chemotherapy followed by Concurrent Chemotherapy and High-Dose Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Cervical Oesophagus
1999
Erythropoietin restores the anemia-induced reduction in radiosensitivity of experimental human tumors in nude mice
2003
Recombinant human erythropoietin increases the radiosensitivity of xenografted human tumours in anaemic nude mice
2001
Kinetics of repair in the spinal cord of the rat
1997
Increased radiation-induced apoptosis and altered cell cycle progression of human lung cancer cell lines by antisense oligodeoxynucleotides targeting p53 and p21WAF1/CIP1
2003
Arginine deiminase and other antiangiogenic agents inhibit unfavorable neuroblastoma growth: Potentiation by irradiation
2003
Prophylactic Cranial Irradiation in Operable Stage IIIA Non–Small-Cell Lung Cancer Treated With Neoadjuvant Chemoradiotherapy: Results From a German Multicenter Randomized Trial
2007
Induction chemotherapy followed by concurrent chemotherapy and definitive high-dose radiotherapy for patients with locally advanced non-small-cell lung cancer (stages IIIa/IIIb):a pilot phase I/II trial
2002
Prophylactic Cranial Irradiation in Locally Advanced Non–Small-Cell Lung Cancer After Multimodality Treatment: Long-Term Follow-Up and Investigations of Late Neuropsychologic Effects
1999
[Accelerated hyperfractionated radiotherapy combined with simultaneous chemotherapy in locally advanced pharyngeal and oral carcinomas].
1994
Radiation‐induced apoptosis in human sarcoma and glioma cell lines
1995